DOC

Older Antipsychotics Trump Newer Agents for Schizophrenia

By Mark Porter,2014-10-18 07:10
23 views 0
Risperidone long-acting injection (RLAI), the first atypical depot antipsychotic, is widely used in Europe and the United States, and its superiority to placebo and oral antipsychotics has been shown in several randomized controlled trials, Dr. Nielsen said. "Only a few studies have compared RLAI with the conventional depot formulation, so we decided to look at this issue in a large population using our Danish nationwide registers," he said.
null
null

Report this document

For any questions or suggestions please email
cust-service@docsford.com